Initiation of cardioprotective glucose-lowering drugs according to sex and educational level: a Danish nationwide cohort study

被引：0
|
作者：
Calderon, E. [1 ,2 ]
Bjerg, L. [1 ,3 ]
Isaksen, A. A. [1 ,3 ]
Sandbaek, A. [1 ,3 ]
Funck, K. L. [1 ]
Grove, E. L. [2 ,4 ]
机构：
[1] Aarhus Univ Hosp, Steno Diabet Ctr Aarhus, Aarhus, Denmark
[2] Aarhus Univ Hosp, Dept Cardiol, Aarhus, Denmark
[3] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark
[4] Aarhus Univ, Dept Clin Med, Hlth, Aarhus, Denmark
来源：
DIABETOLOGIA | 2024年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
400
引用
收藏
页码：S202 / S202
页数：1
相关论文
共 50 条
  • [1] Gender disparities in time-to-initiation of cardioprotective glucose-lowering drugs in patients with type 2 diabetes and cardiovascular disease: a Danish nationwide cohort study
    Funck, Kristian Lokke
    Bjerg, Lasse
    Isaksen, Anders Aasted
    Sandbaek, Annelli
    Grove, Erik Lerkevang
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [2] Gender disparities in time-to-initiation of cardioprotective glucose-lowering drugs in patients with type 2 diabetes and cardiovascular disease: a Danish nationwide cohort study
    Kristian Løkke Funck
    Lasse Bjerg
    Anders Aasted Isaksen
    Annelli Sandbæk
    Erik Lerkevang Grove
    Cardiovascular Diabetology, 21
  • [3] Changes in the use of glucose-lowering drugs: A Danish nationwide study
    Pottegard, Anton
    Andersen, Jacob H.
    Sondergaard, Jens
    Thomsen, Reimar W.
    Vilsboll, Tina
    DIABETES OBESITY & METABOLISM, 2023, 25 (04): : 1002 - 1010
  • [4] Changes in use of glucose-lowering drugs and physician responsibility: A Danish nationwide study
    Pottegard, Anton
    Thomsen, Reimar
    Andersen, Jacob Harbo
    Sondergaard, Jens
    Vilsboll, Tina
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 183 - 184
  • [5] Gender disparities in time-to-initiation of cardioprotective glucose-lowering drugs in patients with type 2 diabetes and cardiovascular disease: a nationwide cohort study
    Funck, K. L.
    Bjerg, L.
    Isaksen, A. A.
    Sandbaek, A.
    Grove, E. L.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S176 - S176
  • [6] Real-world use of cardioprotective glucose-lowering drugs in patients with type 2 diabetes and cardiovascular disease: A Danish nationwide cohort study, 2012 to 2019
    Funck, Kristian L.
    Knudsen, Jakob S.
    Hansen, Troels K.
    Thomsen, Reimar W.
    Grove, Erik L.
    DIABETES OBESITY & METABOLISM, 2021, 23 (02): : 520 - 529
  • [7] Age discrepencies in the use of glucose-lowering medications: a nationwide cohort study
    Johansson, K.
    Petersen, T.
    Christensen, M.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S95 - S96
  • [8] Second-line glucose-lowering drugs added to metformin and the risk of hospitalization for heart failure: A nationwide cohort study
    Lee, Su Jin
    Ha, Kyoung Hwa
    Lee, Jung Hyun
    Lee, Hokyou
    Kim, Dae Jung
    Kim, Hyeon Chang
    PLOS ONE, 2019, 14 (02):
  • [9] Assessment of channeling bias among initiators of glucose-lowering drugs: A UK cohort study
    Ankarfeldt, Mikkel Z.
    Thorsted, Brian L.
    Groenwold, Rolf H. H.
    Adalsteinsson, Erpur
    Ali, M. Sanni
    Klungel, Olaf H.
    CLINICAL EPIDEMIOLOGY, 2017, 9 : 19 - 30
  • [10] Initiation of glucose-lowering diabetes drugs decreases the blood thinning effect of warfarin
    Dunvald, A.
    Pottegard, A.
    Stage, T.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) : S77 - S77
12345